Goal: To inform nephrology nurses about the manifestations and treatment for the renal involvement of Von Hippel-Lindau Disease.
Objectives:
Describe the genetic basis for the tumor development in Von Hippel-Lindau Disease.
Compare the treatments used for patients with renal carcinomas caused by Von Hippel-Lindau Disease.
Develop an education plan for patients with a family history of Von Hippel-Lindau Disease.
Acknowledgments: Special thanks to Drs. Elaine Patterson and Kathleen Burke of UMDNJ for all the encouragement. No funding was received for this publication.
Note: The author reported no actual or potential conflict of interest in relation to this continuing education article.